{"id":"W2006827588","doi":"10.1038/bjc.2014.497","title":"A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Moffitt Cancer Center","keywords":"Medicine; Rash; Internal medicine; PI3K/AKT/mTOR pathway; Cancer; Oncology; Pharmacology; Biology; Signal transduction; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001626197,0.002111629,0.001968582,0.0004078306,0.000331748,0.001253587,0.001058997,0.001083585,0.004164302],"category_scores_gemma":[0.0008882213,0.000637784,0.00137987,0.0003883374,0.001408634,0.0009483592,0.0005736644,0.003107148,0.001062414],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001237719,"about_ca_system_score_gemma":0.001627667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008297917,"about_ca_topic_score_gemma":0.001623295,"domain_scores_codex":[0.9995845,0.0001419528,0.00002083951,0.0001061229,0.00003587001,0.0001107069],"domain_scores_gemma":[0.9991158,0.00009813432,0.0001911699,0.0001016789,0.00003869953,0.0004544948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9116564,0.03848666,0.002107486,0.0003114371,0.0005286312,0.00007531503,0.0001326232,0.001759244,0.01777313,0.0002137879,0.001086106,0.02586925],"study_design_scores_gemma":[0.6405167,0.3504882,0.004232303,0.00001386691,0.0002761504,0.0001116453,0.00004040034,0.0007411828,0.002163692,0.000169493,0.001225165,0.00002114497],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946136,0.0007688313,0.000354063,0.0002153089,0.0001400996,0.001990258,0.0006327736,0.00005348417,0.001231594],"genre_scores_gemma":[0.9903211,0.0009737018,0.001332389,0.000512571,0.0001729885,0.002683685,0.001478147,0.00002107053,0.002504284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004164302,"threshold_uncertainty_score":0.01393098,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006350034164310448,"score_gpt":0.2746686210074111,"score_spread":0.2683185868431006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}